Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Yoshida: Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance.... (0.08 sec) 

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance …

- annals.org [PDF] 
H Yoshida, Y Shiratori, M Moriyama, Y … - Annals of internal medicine, 1999 - Am Coll Physicians
Haruhiko Yoshida, MD; Yasushi Shiratori, MD; Mitsuhiko Moriyama, MD; Yasuyuki
Arakawa, MD; Tatsuya Ide, MD; Michio Sata, MD; Osami Inoue, MD; Michitami Yano,
MD; Motohiko Tanaka, MD; Shigetoshi Fujiyama, MD; Shuhei Nishiguchi, MD; ...
Cited by 508 - Related articles - BL Direct - All 6 versions

Randomised trial of effects of interferon-[alpha] on incidence of hepatocellular carcinoma in …


S Nishiguchi, T Kuroki, S Nakatani, H … - The Lancet, 1995 - Elsevier
In a prospective randomised controlled trial, we evaluated the effects of IFN-α
in cirrhotic patients with HCV infection because of their high risk of
hepatocellular carcinoma. 90 patients with compensated chronic active ...
Cited by 654 - Related articles - BL Direct - All 7 versions

[PDF] Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic …


K Ikeda, S Saitoh, Y Arase, K Chayama, Y … - Hepatology, 1999 - journals.pasteur.ac.ir
The activity of interferon (IFN) is not elucidated from the viewpoint of cancer
prevention in chronic hepatitis C patients en masse. The hepatocellular
carcinogenesis rate was analyzed statistically in 1,643 patients with ...
Cited by 241 - Related articles - BL Direct - All 5 versions

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in …


A Kasahara, N Hayashi, K Mochizuki, M … - Hepatology, 1998 - interscience.wiley.com
To elucidate the risk factors for liver carcinogenesis and to examine the
incidence of hepatocellular carcinoma (HCC) after interferon therapy, 1,022
chronic hepatitis C patients treated with interferon were followed by ...
Cited by 274 - Related articles - BL Direct - All 3 versions

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic …

- annals.org
Y Imai, S Kawata, S Tamura, I Yabuuchi, S … - Annals of internal medicine, 1998 - Am Coll Physicians
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: The effect of interferon therapy on the incidence of ...
Cited by 185 - Related articles - BL Direct - All 4 versions

Histologic improvement of fibrosis in patients with hepatitis C who have sustained response …

- annals.org [PDF] 
Y Shiratori, F Imazeki, M Moriyama, M Yano, … - Annals of internal medicine, 2000 - Am Coll Physicians
Yasushi Shiratori, MD; Fumio Imazeki, MD; Mitsuhiko Moriyama, MD; Michitami
Yano, MD; Yasuyuki Arakawa, MD; Osamu Yokosuka, MD; Tetsuo Kuroki, MD†; Shuhei
Nishiguchi, MD; Michio Sata, MD; Gotarou Yamada, MD; Shigetoshi Fujiyama, ...
Cited by 342 - Related articles - BL Direct - All 5 versions

Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic …


T Okanoue, Y Itoh, M Minami, S Sakamoto, K … - Journal of hepatology, 1999 - Elsevier
Results: Sustained (SR: 27.5%) and transient (TR: 23.0%) responders totaled
50.5%, while 49.5% did not respond to interferon. SR showed an improvement in
disease stage reflected by increased platelet counts. Fifty-two patients (9 ...
Cited by 117 - Related articles - BL Direct - All 5 versions

Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon …


DC Valla, M Chevallier, P Marcellin… - Gastroenterology, 1999 - medscape.com
Journal Scan is the clinician's guide to the latest clinical research findings
in Gastroenterology, Hepatology, Gastrointestinal Endoscopy, and The New England
Journal of Medicine. Short summaries of feature articles include links to ...
Cited by 128 - Related articles - BL Direct - All 4 versions

Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based …


C Cammā, M Giunta, P Andreone, A Craxė - Journal of Hepatology, 2001 - Elsevier
Methods: Three randomized controlled trials and 15 nonrandomized controlled
trials, including 4614 patients and comparing IFN to no treatment, were
selected. Data on the incidence of HCC in IFN treated and untreated ...
Cited by 220 - Related articles - BL Direct - All 5 versions

Interferon therapy prolonged life expectancy among chronic hepatitis C patients


H Yoshida, Y Arakawa, M Sata, S Nishiguchi, … - Gastroenterology, 2002 - Elsevier
*1 Supported in part by the Ministry of Health, Labour, and Welfare of Japan as
one of the Comprehensive 10-Year Strategy for Cancer Control Projects and of
Medical Frontier Strategy Researches and in part by the Ministry of ...
Cited by 128 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google